Nellix raises $6.5M for aneurysm grafts
Nellix Endovascular, a Palo Alto, Calif., medical-device maker, raised $6.5 million in a third funding round, I’ve learned. The startup is developing a new treatment for repairing blood-vessel flaws in the chest and abdomen.
Those flaws, known as aneurysms, are thin-walled “bubbles” in blood vessels that can rupture on short notice, often fatally. The Nellix device and treatment apparently injects some form of goop into these aneurysms, filling and sealing them in order to prevent rupture.
Investors in the round included Essex Woodlands Health Ventures and Incept.
Next Story: Miramar Labs gets $20M for “aesthetic” devices
Previous Story: Defibrillator maker Cameron Health takes in $14M
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.